Corvidia is a pharmaceutical firm that develops and commercializes novel therapeutics for the treatment of cardiorenal and chronic kidney disorders.
Business Model:
Revenue: $7.2M
Employees: 11-50
Corvidia was acquired by
Novo Nordisk.
The acquisition happend on 2020-06-11.
Details of the transaction were not public
Address: 35 Gatehouse Drive
City: Waltham
State: MA
Zip: 02451
Country: US
Corvidia is a pharmaceutical firm that develops and commercializes novel therapeutics for the treatment of cardiorenal and chronic kidney disorders.
Contact Phone:
+17812054755
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2016 | Series A | 2 | $26M |
Apple Tree Partners Sofinnova Partners Apple Tree Partners Sofinnova Partners |
4/2018 | Series B | 9 | $60M |
Sofinnova Partners MedImmune Andera Partners Cormorant Asset Management HBM Healthcare Investments AG Venrock Fresenius Medical Care Apple Tree Partners Venrock Healthcare Capital Partners Venrock Sofinnova Partners MedImmune Andera Partners Cormorant Asset Management HBM Healthcare Investments AG Venrock Fresenius Medical Care Apple Tree Partners Venrock Healthcare Capital Partners Venrock |
3/2020 | Convertible Note | 1 | $827.3k |
HBM Healthcare Investments AG HBM Healthcare Investments AG |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|